TrialEuropean journal of drug metabolism and pharmacokinetics2025

A Phase I Study to Evaluate the Relative Bioavailability, Pharmacodynamics, and Safety of a Single Subcutaneous Injection of Recaticimab at Three Different Sites in Healthy Chinese Subjects.

Ying Wang et al.PubMed ↗Publisher ↗

No numbers read from the abstract.